Diasorin SpA (EUR)
DIA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range109.60 | 113.40
52-Wk Range82.90 | 125.00
Last Close116.30
Mkt Cap (m)6,364.24
Dividend yield0.77%
ISINIT0003492391
Volume285,957
Exchange VenueMIL

Company Profile

Diasorin SpA is engaged in the development, manufacture and distribution ofimmunodiagnostics and molecular diagnostics tests.

Key Information
Price/Earning38.38
Price/Book7.85
Price/Sales9.09
P/CF25.71
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Annual Report
en 31/12/2017

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)444499569637669-
Operating Income (m)132156178198210-
Net Income (m)84100112140158-
Basic EPS1.551.832.052.542.85-
Avg. Diluted Shares Outstanding (m)5455555556-
Balance Sheet
EUR201420152016201720182019
Current Assets (m)391494395482415-
Non Current Assets (m)215214473460491-
Total Assets (m)606708869946906-
Current Liabilities (m)8282132141138-
Total Liabilities (m)------
Total Equity (m)483587663741705-
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)120138166167210-
Capital Expenditure (m)-31-32-37-42-53-
Figures are quoted in EUR unless stated otherwise
-5.70 (-4.90%)
110.60
Last Price